$HTBI
HomeTrust Bancshares, Inc. Stock $htbi

$htbi Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000153826317000044 Filed on November 09, 2017

Income Statement

Concept	2017 Q3	2016 Q3
Revenue	$27.90M	$22.79M
YoY Change	22.4%	3.55%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$836.0K	$868.0K
YoY Change	-3.69%	-17.02%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$3.315M	$1.654M
YoY Change	100.42%	15.02%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$8.077M	$6.248M
YoY Change	29.27%	52.2%
Income Tax	$2.510M	$2.424M
% Of Pretax Income	31.08%	38.8%
Net Earnings	$5.567M	$3.824M
YoY Change	45.58%	49.14%
Net Earnings / Revenue	19.96%	16.78%
Basic Earnings Per Share	$0.31	$0.22
Diluted Earnings Per Share	$0.30	$0.22
COMMON SHARES
Basic Shares Outstanding	17.97M shares	17.21M shares
Diluted Shares Outstanding	18.62M shares	17.45M shares

Balance Sheet

Concept	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$78.97M	$60.56M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$62.61M	$53.98M
YoY Change	15.99%	-5.13%
Goodwill	$25.64M	$12.67M
YoY Change	102.3%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$55.70M	$52.10M
YoY Change	6.91%	-9.39%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$3.250B	$2.754B
YoY Change	18.01%	1.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$1.900M	$2.000M
YoY Change	-5.0%	0.0%
Other Long-Term Liabilities	$62.50M	$57.70M
YoY Change	8.32%	-3.67%
Total Long-Term Liabilities	$64.40M	$59.70M
YoY Change	7.87%	-3.55%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$64.40M	$59.70M
Total Liabilities	$2.844B	$2.390B
YoY Change	19.03%	1.35%
SHAREHOLDERS EQUITY
Retained Earnings	$197.9M	$183.6M
YoY Change	7.77%	7.44%
Common Stock	$190.0K	$180.0K
YoY Change	5.56%	-5.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$405.5M	$364.4M
YoY Change
Total Liabilities & Shareholders Equity	$3.250B	$2.754B
YoY Change	18.01%	1.03%

Cashflow Statement

Concept	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	$5.567M	$3.824M
YoY Change	45.58%	49.14%
Depreciation, Depletion And Amortization	$836.0K	$868.0K
YoY Change	-3.69%	-17.02%
Cash From Operating Activities	$7.161M	-$3.008M
YoY Change	-338.07%	-126.08%
INVESTING ACTIVITIES
Capital Expenditures	$561.0K	$628.0K
YoY Change	-10.67%	49.52%
Acquisitions
YoY Change
Other Investing Activities	-$49.78M	-$24.72M
YoY Change	101.38%	33.62%
Cash From Investing Activities	-$50.34M	-$25.35M
YoY Change	98.56%	34.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$35.17M	$36.33M
YoY Change	-3.2%	-162.05%
NET CHANGE
Cash From Operating Activities	$7.161M	-$3.008M
Cash From Investing Activities	-$50.34M	-$25.35M
Cash From Financing Activities	$35.17M	$36.33M
Net Change In Cash	-$8.014M	$7.967M
YoY Change	-200.59%	-112.08%
FREE CASH FLOW
Cash From Operating Activities	$7.161M	-$3.008M
Capital Expenditures	$561.0K	$628.0K
Free Cash Flow	$6.600M	-$3.636M
YoY Change	-281.52%	-132.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q3	dei	Amendment Flag AmendmentFlag	false
CY2017Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2017Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2017Q3	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
CY2017Q3	dei	Document Type DocumentType	10-Q
CY2017Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001538263
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18962075	shares
CY2017Q3	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q3	dei	Entity Registrant Name EntityRegistrantName	HomeTrust Bancshares, Inc.
CY2017Q3	htbi	Available For Sale Securities Debt Maturities Amortized Cost1 AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost1	181418000	USD
CY2016Q3	htbi	Capital Improvements To Reo CapitalImprovementsToReo	0	USD
CY2017Q3	htbi	Capital Improvements To Reo CapitalImprovementsToReo	18000	USD
CY2016Q3	htbi	Core Deposit Intangible Amortization CoreDepositIntangibleAmortization	650000	USD
CY2017Q3	htbi	Core Deposit Intangible Amortization CoreDepositIntangibleAmortization	719000	USD
CY2016Q3	htbi	Deferredincometaxexpense Deferredincometaxexpense	2266000	USD
CY2017Q3	htbi	Deferredincometaxexpense Deferredincometaxexpense	2361000	USD
CY2016Q3	htbi	Employee Stock Ownership Plan Value Of Allocated Shares EmployeeStockOwnershipPlanValueOfAllocatedShares	249000	USD
CY2017Q3	htbi	Employee Stock Ownership Plan Value Of Allocated Shares EmployeeStockOwnershipPlanValueOfAllocatedShares	315000	USD
CY2013Q1	htbi	Equity Incentive Plan Name EquityIncentivePlanName	2013 Omnibus Incentive Plan
CY2017Q3	htbi	Impaired Financing Receivable Loans Excludedfrom Recorded Investment ImpairedFinancingReceivableLoansExcludedfromRecordedInvestment	6491000	USD
CY2017Q2	htbi	Impaired Loans Not Individually Evaluated ImpairedLoansNotIndividuallyEvaluated	22023000	USD
CY2017Q3	htbi	Impaired Loans Not Individually Evaluated ImpairedLoansNotIndividuallyEvaluated	18765000	USD
CY2017Q2	htbi	Loans And Leases Receivable Deferred Loan Costs Net LoansAndLeasesReceivableDeferredLoanCostsNet	-945000	USD
CY2017Q3	htbi	Loans And Leases Receivable Deferred Loan Costs Net LoansAndLeasesReceivableDeferredLoanCostsNet	-1285000	USD
CY2016Q3	htbi	Loss Gain On Sale And Impairment Of Reo LossGainOnSaleAndImpairmentOfReo	-129000	USD
CY2017Q3	htbi	Loss Gain On Sale And Impairment Of Reo LossGainOnSaleAndImpairmentOfReo	146000	USD
CY2016Q3	htbi	Maturities Of Certificates Of Deposit In Other Banks MaturitiesOfCertificatesOfDepositInOtherBanks	21835000	USD
CY2017Q3	htbi	Maturities Of Certificates Of Deposit In Other Banks MaturitiesOfCertificatesOfDepositInOtherBanks	29010000	USD
CY2016Q3	htbi	Maturitiesofcommercialpaper Maturitiesofcommercialpaper	9724000	USD
CY2017Q3	htbi	Maturitiesofcommercialpaper Maturitiesofcommercialpaper	-49278000	USD
CY2016Q3	htbi	Net Interest Income After Recovery For Loan Losses NetInterestIncomeAfterRecoveryForLoanLosses	21137000	USD
CY2017Q3	htbi	Net Interest Income After Recovery For Loan Losses NetInterestIncomeAfterRecoveryForLoanLosses	24581000	USD
CY2016Q3	htbi	Net Redemptions Purchases Of Other Investments NetRedemptionsPurchasesOfOtherInvestments	-2023000	USD
CY2017Q3	htbi	Net Redemptions Purchases Of Other Investments NetRedemptionsPurchasesOfOtherInvestments	704000	USD
CY2017Q2	htbi	Numberof Securities With Unrealized Losses NumberofSecuritiesWithUnrealizedLosses	136	security
CY2017Q3	htbi	Numberof Securities With Unrealized Losses NumberofSecuritiesWithUnrealizedLosses	107	security
CY2016Q3	htbi	Purchase Of Bank Owned Life Insurance PurchaseOfBankOwnedLifeInsurance	24000	USD
CY2017Q3	htbi	Purchase Of Bank Owned Life Insurance PurchaseOfBankOwnedLifeInsurance	18000	USD
CY2016Q3	htbi	Purchase Of Certificates Of Deposit In Other Banks PurchaseOfCertificatesOfDepositInOtherBanks	13754000	USD
CY2017Q3	htbi	Purchase Of Certificates Of Deposit In Other Banks PurchaseOfCertificatesOfDepositInOtherBanks	7190000	USD
CY2016Q3	htbi	Real Estate Owned Cost Of Sales RealEstateOwnedCostOfSales	546000	USD
CY2017Q3	htbi	Real Estate Owned Cost Of Sales RealEstateOwnedCostOfSales	647000	USD
CY2016Q3	htbi	Realestateownedcapitalimprovements Realestateownedcapitalimprovements	0	USD
CY2017Q3	htbi	Realestateownedcapitalimprovements Realestateownedcapitalimprovements	18000	USD
CY2017Q2	htbi	Recorded Allowance Of Impaired Loans Not Individually Evaluated RecordedAllowanceOfImpairedLoansNotIndividuallyEvaluated	41000	USD
CY2017Q3	htbi	Recorded Allowance Of Impaired Loans Not Individually Evaluated RecordedAllowanceOfImpairedLoansNotIndividuallyEvaluated	42000	USD
CY2017Q2	htbi	Securities Available For Sale Pledged As Collateral Market Value SecuritiesAvailableForSalePledgedAsCollateralMarketValue	154264000	USD
CY2017Q3	htbi	Securities Available For Sale Pledged As Collateral Market Value SecuritiesAvailableForSalePledgedAsCollateralMarketValue	141284000	USD
CY2017Q3	htbi	Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Intrinsic Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedIntrinsicValue	4161000	USD
CY2017Q3	htbi	Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P5Y2M12D
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	273000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	378000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	213459000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	214827000	USD
CY2016Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	377000	USD
CY2017Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	428000	USD
CY2016Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	362000	USD
CY2017Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	745000	USD
CY2017Q2	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	696500000	USD
CY2017Q3	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	679800000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	739000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1170000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	21151000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	21997000	USD
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	685000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1009000	USD
CY2016Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	1026000	USD
CY2017Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	163000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	46500	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	60500	shares
CY2017Q2	us-gaap	Assets Assets	3206533000	USD
CY2017Q3	us-gaap	Assets Assets	3249998000	USD
CY2017Q2	us-gaap	Assets Fair Value Disclosure Nonrecurring AssetsFairValueDisclosureNonrecurring	13200000	USD
CY2017Q3	us-gaap	Assets Fair Value Disclosure Nonrecurring AssetsFairValueDisclosureNonrecurring	8711000	USD
CY2017Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	199667000	USD
CY2017Q3	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	182053000	USD
CY2017Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	199667000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	182053000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1112000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1181000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	698000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	609000	USD
CY2017Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	199253000	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	181481000	USD
CY2016Q3	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax	-387000	USD
CY2017Q3	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax	105000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	120000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	214000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	698000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	609000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	113466000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	91506000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	578000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	395000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	102575000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	69797000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	10891000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	21709000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	14767000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	15172000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	68093000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	68016000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	9739000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	9799000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1914000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1919000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	181990000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2017Q2	us-gaap	Available For Sale Securities Pledged As Collateral AvailableForSaleSecuritiesPledgedAsCollateral	156592000	USD
CY2017Q3	us-gaap	Available For Sale Securities Pledged As Collateral AvailableForSaleSecuritiesPledgedAsCollateral	140948000	USD
CY2017Q2	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	85981000	USD
CY2017Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	86561000	USD
CY2016Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	562000	USD
CY2017Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	562000	USD
CY2016Q3	us-gaap	Business Combination Separately Recognized Transactions Expenses And Losses Recognized BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized	307000	USD
CY2017Q3	us-gaap	Business Combination Separately Recognized Transactions Expenses And Losses Recognized BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized	0	USD
CY2017Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	1937000	USD
CY2017Q3	us-gaap	Capital Lease Obligations CapitalLeaseObligations	1931000	USD
CY2017Q2	us-gaap	Cash Cash	41982000	USD
CY2017Q3	us-gaap	Cash Cash	38162000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52596000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60563000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86985000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78971000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7967000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8014000	USD
CY2017Q2	us-gaap	Cash Reserve Deposit Required And Made CashReserveDepositRequiredAndMade	2152000	USD
CY2017Q3	us-gaap	Cash Reserve Deposit Required And Made CashReserveDepositRequiredAndMade	1109000	USD
CY2017Q1	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet	258059000	USD
CY2017Q2	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	132274000	USD
CY2017Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	110454000	USD
CY2017Q2	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	149863000	USD
CY2017Q3	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	199774000	USD
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17998750	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18968675	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17998750	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18968675	shares
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	190000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	190000	USD
CY2016Q3	us-gaap	Communication Communication	612000	USD
CY2017Q3	us-gaap	Communication Communication	685000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3437000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5672000	USD
CY2016Q3	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2017Q3	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	680000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	57387000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	55653000	USD
CY2017Q2	us-gaap	Deposits Deposits	2048451000	USD
CY2017Q3	us-gaap	Deposits Deposits	2100310000	USD
CY2016Q3	us-gaap	Depreciation Depreciation	868000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	836000	USD
CY2016Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	-2180000	USD
CY2017Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	-1187000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2016Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	274000	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	421000	USD
CY2016Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	249000	USD
CY2017Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	315000	USD
CY2017Q2	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	616483000	USD
CY2017Q3	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	681583000	USD
CY2016Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	279000	USD
CY2017Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	414000	USD
CY2016Q3	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	1914000	USD
CY2017Q3	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	2039000	USD
CY2016Q3	us-gaap	Fees And Commissions Mortgage Banking FeesAndCommissionsMortgageBanking	976000	USD
CY2017Q3	us-gaap	Fees And Commissions Mortgage Banking FeesAndCommissionsMortgageBanking	1102000	USD
CY2016Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21292000	USD
CY2016Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	20951000	USD
CY2017Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21151000	USD
CY2017Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21997000	USD
CY2017Q2	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	18881000	USD
CY2017Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	19041000	USD
CY2017Q2	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1543000	USD
CY2017Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1759000	USD
CY2016Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	USD
CY2017Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	USD
CY2017Q2	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	2299932000	USD
CY2017Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	2343531000	USD
CY2017Q2	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	20942000	USD
CY2017Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	23055000	USD
CY2016Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	6	loan
CY2017Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	10	loan
CY2016Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	227000	USD
CY2017Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	1514000	USD
CY2016Q3	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	227000	USD
CY2017Q3	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	1514000	USD
CY2016Q3	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	9	loan
CY2017Q3	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	4	loan
CY2016Q3	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	1437000	USD
CY2017Q3	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	1044000	USD
CY2017Q2	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2017Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2017Q2	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2337193000	USD
CY2017Q3	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2378360000	USD
CY2017Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	13666000	USD
CY2017Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	14085000	USD
CY2017Q2	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	15222000	USD
CY2017Q3	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	17680000	USD
CY2017Q2	us-gaap	Finite Lived Core Deposits Gross FiniteLivedCoreDepositsGross	7173000	USD
CY2017Q3	us-gaap	Finite Lived Core Deposits Gross FiniteLivedCoreDepositsGross	6454000	USD
CY2016Q3	us-gaap	Foreclosed Real Estate Expense ForeclosedRealEstateExpense	144000	USD
CY2017Q3	us-gaap	Foreclosed Real Estate Expense ForeclosedRealEstateExpense	241000	USD
CY2016Q3	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	382000	USD
CY2017Q3	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	704000	USD
CY2016Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	385000	USD
CY2017Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	164000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	25638000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	25638000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	43868000	USD
CY2017Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	42395000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	549000	USD
CY2017Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	477000	USD
CY2017Q2	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	42965000	USD
CY2017Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	41820000	USD
CY2017Q2	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1584000	USD
CY2017Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1801000	USD
CY2017Q2	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	56354000	USD
CY2017Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	54098000	USD
CY2017Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	15321000	USD
CY2017Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	13043000	USD
CY2017Q2	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	27644000	USD
CY2017Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	28777000	USD
CY2017	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2017Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6248000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8077000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.22
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.31
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.22
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.30
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2424000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2510000	USD
CY2016Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	USD
CY2017Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	20000	USD
CY2016Q3	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4320000	USD
CY2017Q3	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	460000	USD
CY2016Q3	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-9168000	USD
CY2017Q3	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	51859000	USD
CY2016Q3	us-gaap	Increase Decrease In Loans Deferred Income IncreaseDecreaseInLoansDeferredIncome	5000	USD
CY2017Q3	us-gaap	Increase Decrease In Loans Deferred Income IncreaseDecreaseInLoansDeferredIncome	-340000	USD
CY2016Q3	us-gaap	Increase Decrease In Other Loans IncreaseDecreaseInOtherLoans	-45500000	USD
CY2017Q3	us-gaap	Increase Decrease In Other Loans IncreaseDecreaseInOtherLoans	16700000	USD
CY2016Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1232000	USD
CY2017Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	365000	USD
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	242613	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	649458	shares
CY2016Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1427000	USD
CY2017Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1545000	USD
CY2016Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	22791000	USD
CY2017Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	27896000	USD
CY2016Q3	us-gaap	Interest And Dividend Income Securities Available For Sale InterestAndDividendIncomeSecuritiesAvailableForSale	880000	USD
CY2017Q3	us-gaap	Interest And Dividend Income Securities Available For Sale InterestAndDividendIncomeSecuritiesAvailableForSale	971000	USD
CY2016Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	20480000	USD
CY2017Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	25250000	USD
CY2017Q2	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	45003000	USD
CY2017Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	40809000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	1654000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	3315000	USD
CY2016Q3	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	555000	USD
CY2017Q3	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1969000	USD
CY2016Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1099000	USD
CY2017Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1346000	USD
CY2016Q3	us-gaap	Interest Income Domestic Deposits InterestIncomeDomesticDeposits	1044000	USD
CY2017Q3	us-gaap	Interest Income Domestic Deposits InterestIncomeDomesticDeposits	1169000	USD
CY2016Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21137000	USD
CY2017Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	24581000	USD
CY2016Q3	us-gaap	Interest Paid InterestPaid	2129000	USD
CY2017Q3	us-gaap	Interest Paid InterestPaid	3379000	USD
CY2017Q2	us-gaap	Interest Receivable InterestReceivable	8758000	USD
CY2017Q3	us-gaap	Interest Receivable InterestReceivable	9340000	USD
CY2016Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	387000	USD
CY2017Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	506000	USD
CY2016Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10691000	USD
CY2017Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	12352000	USD
CY2017Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	5164000	USD
CY2017Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	7054000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	2808886000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	2844499000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3206533000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3249998000	USD
CY2017Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	414373000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	449261000	USD
CY2017Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	21151000	USD
CY2017Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	21997000	USD
CY2015	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	22509000	USD
CY2017Q3	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	28619000	USD
CY2015	us-gaap	Loans And Leases Receivable Commitments Variable Rates LoansAndLeasesReceivableCommitmentsVariableRates	21221000	USD
CY2017Q3	us-gaap	Loans And Leases Receivable Commitments Variable Rates LoansAndLeasesReceivableCommitmentsVariableRates	22909000	USD
CY2017Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2352415000	USD
CY2017Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2396040000	USD
CY2017Q2	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	2351470000	USD
CY2017Q3	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	2394755000	USD
CY2017Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2330319000	USD
CY2017Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2372758000	USD
CY2017Q2	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group Other LoansReceivableHeldForSaleNetNotPartOfDisposalGroupOther	5607000	USD
CY2017Q3	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group Other LoansReceivableHeldForSaleNetNotPartOfDisposalGroupOther	7793000	USD
CY2016Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	430000	USD
CY2017Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	453000	USD
CY2016Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36327000	USD
CY2017Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35165000	USD
CY2016Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25352000	USD
CY2017Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50340000	USD
CY2016Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3008000	USD
CY2017Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7161000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	3824000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	5567000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3769000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5510000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3770000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5512000	USD
CY2016Q3	us-gaap	Noninterest Expense NoninterestExpense	19130000	USD
CY2017Q3	us-gaap	Noninterest Expense NoninterestExpense	21081000	USD
CY2016Q3	us-gaap	Noninterest Income NoninterestIncome	4241000	USD
CY2017Q3	us-gaap	Noninterest Income NoninterestIncome	4577000	USD
CY2016Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	404000	USD
CY2017Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	710000	USD
CY2017Q2	us-gaap	Notes Receivable Net NotesReceivableNet	2320874000	USD
CY2017Q3	us-gaap	Notes Receivable Net NotesReceivableNet	2366586000	USD
CY2016Q3	us-gaap	Occupancy Net OccupancyNet	2061000	USD
CY2017Q3	us-gaap	Occupancy Net OccupancyNet	2349000	USD
CY2017Q2	us-gaap	Other Assets OtherAssets	7560000	USD
CY2017Q3	us-gaap	Other Assets OtherAssets	7343000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	199000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	-53000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-387000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	105000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-586000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	158000	USD
CY2017Q2	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	39355000	USD
CY2017Q3	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	38651000	USD
CY2017Q2	us-gaap	Other Liabilities OtherLiabilities	61998000	USD
CY2017Q3	us-gaap	Other Liabilities OtherLiabilities	62458000	USD
CY2016Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2400000	USD
CY2017Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2469000	USD
CY2016Q3	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	38908000	USD
CY2017Q3	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	32424000	USD
CY2016Q3	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	47513000	USD
CY2017Q3	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	42207000	USD
CY2016Q3	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	13000000	USD
CY2017Q3	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2016Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	628000	USD
CY2017Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	561000	USD
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	12570000	USD
CY2017Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	11680000	USD
CY2016Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS	6649000	USD
CY2017Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS	5822000	USD
CY2016Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2017Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2016Q3	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	36241000	USD
CY2017Q3	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	30942000	USD
CY2016Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	395000	USD
CY2017Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	923000	USD
CY2016Q3	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	417000	USD
CY2017Q3	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	793000	USD
CY2016Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	63648000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62614000	USD
CY2016Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
CY2017Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
CY2016Q2	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	5956000	USD
CY2016Q3	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	5715000	USD
CY2017Q2	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	6318000	USD
CY2017Q3	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	5941000	USD
CY2016Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	5000	USD
CY2017Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	6000	USD
CY2016Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	739000	USD
CY2017Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	1173000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	191660000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	197907000	USD
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	829400	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	989770	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.40
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.96
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	43273	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	500	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	699900	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1529300	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1529300	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1470043	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1425470	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.50
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.50
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.22
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.96
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6117000	USD
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6117000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	13533000	USD
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	15316000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	15.71
CY2016Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2017Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.37
CY2016Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2017Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	23.82
CY2016Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2017Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.35
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11155000	USD
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	435700	shares
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	16.15
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2016Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M18D
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M25D
CY2016Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	400	shares
CY2016Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	800	shares
CY2017Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	USD
CY2013Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	13297000	USD
CY2013	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	846400	shares
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	397647000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	405499000	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	359976000	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	364401000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	397647000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	405499000	USD
CY2016Q3	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	305000	USD
CY2017Q3	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	252000	USD
CY2016Q3	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	305000	USD
CY2017Q3	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	252000	USD
CY2016Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-55000	USD
CY2017Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-57000	USD
CY2016Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	1000	USD
CY2017Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	2000	USD
CY2017Q2	us-gaap	Unearned Esop Shares UnearnedESOPShares	7935000	USD
CY2017Q3	us-gaap	Unearned Esop Shares UnearnedESOPShares	7803000	USD
CY2017Q2	us-gaap	Unused Commitments To Extend Credit UnusedCommitmentsToExtendCredit	43730000	USD
CY2017Q3	us-gaap	Unused Commitments To Extend Credit UnusedCommitmentsToExtendCredit	51528000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17451295	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18616452	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17208682	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17966994	shares
CY2017Q3	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the financial statements. Various elements of the Company's accounting policies, by their nature, are inherently subject to estimation techniques, valuation assumptions, and other subjective assessments. In particular, management has identified several accounting policies that, due to the judgments, estimates and assumptions inherent in those policies, are critical to an understanding of the Company's financial statements. These policies relate to (i) the determination of the provision and the allowance for loan losses, (ii) business combinations and acquired loans, (iii) the valuation of REO, (iv) the valuation of goodwill and other intangible assets, and (v) the valuation of or recognition of deferred tax assets and liabilities. These policies and judgments, estimates and assumptions are described in greater detail in subsequent notes to the Consolidated Financial Statements and Management's Discussion and Analysis of Financial Condition and Results of Operations (Critical Accounting Policies) in our </font><font style="font-family:inherit;font-size:9pt;">2017</font><font style="font-family:inherit;font-size:9pt;"> Form 10-K. Management believes that the judgments, estimates and assumptions used in the preparation of the financial statements are appropriate based on the factual circumstances at the time. However, given the sensitivity of the financial statements to these critical accounting policies, the use of other judgments, estimates and assumptions could result in material differences in the Company's results of operations or financial condition. Further, subsequent changes in economic or market conditions could have a material impact on these estimates and the Company's financial condition and operating results in future periods.</font></div></div>

Files In Submission

Name	View Source	Status
0001538263-17-000044-index-headers.html	Edgar Link	pending
0001538263-17-000044-index.html	Edgar Link	pending
0001538263-17-000044.txt	Edgar Link	pending
0001538263-17-000044-xbrl.zip	Edgar Link	pending
a2017-9x30xhtbix10q.htm	Edgar Link	pending
a2017-9x30xhtbix10qxex101.htm	Edgar Link	pending
a2017-9x30xhtbix10qxex311.htm	Edgar Link	pending
a2017-9x30xhtbix10qxex312.htm	Edgar Link	pending
a2017-9x30xhtbix10qxex32.htm	Edgar Link	pending
exhibit212017socincen_image1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
htbi-20170930.xml	Edgar Link	completed
htbi-20170930.xsd	Edgar Link	pending
htbi-20170930_cal.xml	Edgar Link	unprocessable
htbi-20170930_def.xml	Edgar Link	unprocessable
htbi-20170930_lab.xml	Edgar Link	unprocessable
htbi-20170930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HTBI
HomeTrust Bancshares, Inc. Stock $htbi

2017 Q3 Form 10-Q Financial Statement

#000153826317000044 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HTBI HomeTrust Bancshares, Inc. Stock $htbi

2017 Q3 Form 10-Q Financial Statement

#000153826317000044 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HTBI
HomeTrust Bancshares, Inc. Stock $htbi